Dynavax Technologies Corporation (DVAX)

NASDAQ

$--

(--)

Pre-Market

Dynavax Technologies Corporation (DVAX) Live Price Chart

Last updated: ⁦2026-10-20 13:05:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Dynavax Technologies Corporation (DVAX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Dynavax Technologies Corporation (DVAX) Pre-Market Stock Price

Dynavax Technologies Corporation (DVAX) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing DVAX before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Dynavax Technologies Corporation (DVAX) 7-Day Stock Price Change

Over the past seven days, Dynavax Technologies Corporation (DVAX) moved from $15.48 to $15.50, representing a gain of 0.13% ($0.02).

The stock traded between $15.46 and $15.59 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.

The average daily volume was 3.29 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Dynavax Technologies Corporation (DVAX)?

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies Corporation Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	405
Exchange	NASDAQ
Company Website	https://www.dynavax.com

How to Buy Dynavax Technologies Corporation (DVAX) Stock on MEXC

Eligible investors can buy real shares of Dynavax Technologies Corporation (DVAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DVAX and Place Your Order

Open the RealStocks trading page and search for DVAX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Dynavax Technologies Corporation (DVAX) stock price today?

Dynavax Technologies Corporation (DVAX) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is DVAX stock going up or down today?

As of --, DVAX is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is DVAX pre-market price?

As of --, DVAX is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DVAX after-hours price?

As of --, DVAX is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DVAX stock trading now?

DVAX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DVAX sit relative to its 52-week high and low?

Over the past 52 weeks, DVAX has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Dynavax Technologies Corporation in?

Dynavax Technologies Corporation (DVAX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Dynavax Technologies Corporation's market capitalization and where is it listed?

Dynavax Technologies Corporation is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DVAX valued in terms of P/E ratio and EPS?

DVAX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Dynavax Technologies Corporation pay a dividend?

Dynavax Technologies Corporation pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.